GAMCO Investors’s Elevance Health ELV Stock Holding History

GAMCO Investors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-5,000	Closed	-$1.14M	–	868
2020 Q1	$1.14M	Hold	5,000	–	–	0.01%	526
2019 Q4	$1.51M	Hold	5,000	–	–	0.01%	546
2019 Q3	$1.2M	Hold	5,000	–	–	0.01%	573
2019 Q2	$1.41M	Buy	5,000 +500	+11%	+$137K	0.01%	554
2019 Q1	$1.29M	Buy	+4,500	New	+$1.3M	0.01%	542
2015 Q3	–	Sell	-8,000	Closed	-$1.31M	–	837
2015 Q2	$1.31M	Hold	8,000	–	–	0.01%	579
2015 Q1	$1.24M	Hold	8,000	–	–	0.01%	603
2014 Q4	$1M	Sell	8,000 -15,000	-65%	-$1.85M	0.01%	637
2014 Q3	$2.75M	Hold	23,000	–	–	0.01%	497
2014 Q2	$2.48M	Buy	23,000 +15,000	+188%	+$1.55M	0.01%	519
2014 Q1	$796K	Buy	+8,000	New	+$724K	﹤0.01%	648

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GAMCO Investors's ELV Position: Q2 2020 in Review

GAMCO Investors sold out of Elevance Health (ELV) in Q2 2020, closing a stake of 5,000 shares — an estimated $1.14M sold.

GAMCO Investors first reported a position in ELV in Q1 2014 and held it in 11 quarters. The position peaked at $2.75M in Q3 2014. 1,108 funds tracked by Wall St. Rank hold ELV as of Q2 2020.

GAMCO Investors reported no remaining Elevance Health position as of Q2 2020 after selling out during the quarter.
GAMCO Investors sold 5,000 Elevance Health shares in Q2 2020, an estimated $1.14M.
GAMCO Investors first reported a position in Elevance Health in Q1 2014 and held it in 11 quarters.
GAMCO Investors's Elevance Health position peaked at $2.75M in Q3 2014.
1,108 funds tracked by Wall St. Rank held Elevance Health as of Q2 2020.

Based on GAMCO Investors's 13F filing for Q2 2020, filed 13 Aug 2020.